Navigation Links
Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
Date:4/4/2008

CAMBRIDGE, Mass., April 4, 2008 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present an overview of its Hepatitis C program at the upcoming Canaccord Adams Hepatitis C Conference on Wednesday, April 9, 2008 at 1:30 p.m. ET at the St. Regis Hotel in New York, NY.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
2. Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
3. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
4. Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
5. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
8. ISTA Pharmaceuticals Engages Cowen as Financial Advisor
9. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ewswire/ -- Individuals in consumer-driven health ...itional coverage to exhibit a number of cost-consc...grams, and to be more inclined to think that finan...rding to survey results released today by the nonp.... ,, At the same time, the fifth annual survey...
(Date:12/1/2009)...ages Older Persons and Healthcare Workers to Get I...uthority Data ,, HARRISBURG, Pa., Dec. 1 /PRN...ne preventable deaths occur in those 65 and older,...o highlighted studies in the Pennsylvania Patient ...dvisory . ,, According to the Centers for Disea...
(Date:12/1/2009)...ill honor The Forsyth Institute with an Outstandin... to be held on February 27, 2010, in Washington, D...n & Exhibition. The William J. Gies Awards for Vis...utions to, and support of global oral health and e...es Award winners, visit www.adeagiesfoundation.or...
(Date:12/1/2009)...ntral researcher, funded by the Interdisciplinary ...ainst Women, has launched a new study to examine t...research seeking men in their twenties who had nev...ys Simon Louis Lajeunesse, a postdoctoral student ...The objective of my work is to observe the impact ...
(Date:12/1/2009)...eneral availability of its new Endpoint Management... management capabilities on a single server, singl.... , Scottsdale, AZ (PRWEB...n endpoint management and security, today unveiled...ecurity Suite (LEMSS) that will be delivered as ...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Are the effects of pornography negligible? 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
...ALNUT CREEK, Calif., Nov. 5 Two nonprofit,foundat...l cure of people,affected by genetic conditions kn...ormal merger as of October 31, 2007. The Californi...ces to,the Fragile X community. The agreement cal...
...HICAGO, Nov. 5 - Players for the NFL,s,Chicago Bea...ber 6, 2007,at the North Chicago VA medical center...Celebrity Entertainment Program., Players are sch...ping brighten the day for those who have sacrifice...
... Software Meets 100 Percent of Newly Launched Inpa...Criteria -, ATLANTA, Nov. 5 The Certification Co...HIT(sm)) today announced that the,Eclypsis Corpora...d(sm), and meets the Commission,s newly launched i...
...HIP urges grassroots action during Long-Term Care ...aby Boomers,erroneously believe they have coverage...ey data released today by America,s Health Insuran...g-term care insurance. (Logo: http://www.newscom...
... ROCKVILLE, Maryland November 5, 2007 Human Gen...the final quality-of-life results from a Phase 2b ...ron (albinterferon alfa-2b), in combination with r...ted fewer missed days of work and less impairment ...
...aking more AEDs available in communities could sav...(HealthDay News) -- Compared with cardiopulmonary ...omated external defibrillator (AED) combined with ...ses of 10,663 patients in 11 urban and rural commu...
Other Medicine News:Health News:Fragile X Foundations Sign Merger Agreement 2Health News:Fragile X Foundations Sign Merger Agreement 3Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 2Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 3Health News:Eclipsys Sunrise Acute Care Receives CCHIT Certification 4Health News:New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long-Term Care Expenses 2Health News:New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long-Term Care Expenses 3Health News:HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 2Health News:HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C 3Health News:CPR, Defibrillator Combo Boosts Cardiac Incident Survival 2
(Date:12/1/2009)... , CHICAGO, Dec. 1 At this y...f North America (RSNA), Royal Philips Electronics ...t Workspace, a set of solutions that provides radi...st images at one workspot to help drive quality an... care, Philips will also highlight new capabilitie...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 ...today announced that a new, recently completed pre... comparable toxicity of ANX-514 and Taxotere®...X,s partner for ANX-514 in South Korea, independen... "Our independent confirmation of the bioequivalen...
(Date:12/1/2009)... , REDWOOD CITY, Calif., Dec. 1 /PRNewswire/...its relationship and the signing of its second agr...es Ltd., the world,s largest generic drug manufact...pharmaceutical products. Codexis announced an ear... the new agreement, Teva will use Codexis biocatal...
Breaking Medicine Technology:Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Codexis Expands Collaboration with Teva 2Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 1Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 2A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 1A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 1Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 3
...0 Clinical data from a prospective,registry prese...shows DVT,treatment with the Trellis(R) Peripheral...a Clara, CA) successfully breaks up the blood clot...s technique, called isolated pharmacomechanical th...afely than current catheter-directed thrombolysis,...
...id not achieve statistical significance , , I...: PARS ) today announced results from its Phase ... drug delivery technology formulated with 3% Diclo...andomized, double-blinded, placebo-controlled stud...,s 3% Diclofenac Diethanolamine NanoEmulsion cream...
Other Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2
Ovation BioNatural Pipette, two-stroke, fixed volume, 1L
...ppendorf Reference Series 2000 Pipette is a synony...ct and robust design, and superior operating comfo...operate the measuring stroke and blow-out as well ...tte/tip" system ensures utmost accuracy and precis...
Ovation BioNatural Pipette, two-stroke, fixed volume, 2L
Finnpipette Fixed Volume, 2ul
Medicine Products: